Regnology Acquires Metadata Technology
Regnology, a leading software provider with a focus on regulatory reporting solutions, announces today the acquisition of Metadata Technology (Metadata), a UK-based provider of Statistical Data and Metadata eXchange (SDMX) solutions for central banks and national statistics authorities.
SDMX is an ISO standard designed to describe statistical data and metadata and improve efficient sharing across statistical organisations and institutions. SDMX is sponsored by seven international organisations; see sdmx.org for more information. It is the most widely adopted standard from international organisations and national statistical offices.
Founded in 2005 by consultants who developed SDMX standards, Metadata is a specialist provider of SDMX solutions, software tools, and related consultancy. The offer complements Regnology’s 2021 acquisition of Vizor SupTech, an integrated data collection software used by regulators around the world.
Metadata’s software solutions are built on open-source technology, in particular, the Fusion Metadata Registry (FMR) – see sdmx.io for more information - which currently empowers over 450 statistical agencies in 150+ countries with structural SDMX metadata registries. The latest generation of its cloud-enabled commercial software, Fusion Registry, provides international organisations with the additional capabilities needed to support the complete data lifecycle from collection, integration, storage, and processing through to the dissemination of aggregated data.
Chris Nelson, CEO of Metadata and founder of the SDMX protocol added: “Looking back into 2005, the ambition behind the introduction of SDMX was to reduce the cost and time-to-market of statistical data and metadata. Fast-forward to today, we help empower a vibrant and ever-growing global SDMX community with better-quality statistics. We are confident this acquisition will pave the way for more benefits in the future.”
Commenting on the acquisition Maciej Piechocki, Chief Revenue Officer at Regnology: “The team at Metadata has built a stand-out technology trusted by central banks and statistical agencies across the globe. We are committed to pursuing the effort to foster widespread SDMX adoption to alleviate the strain of reporting and further increase statistical processing efficiency. Through the deal, we are also pleased to be able to bring an enhanced offering to our existing community of regulators and authority bodies.”
Regnology’s regulatory technology makes it easier for central banks, regulators, and supervisory authorities to collect the right data, identify risks and gain insight to make decisions faster in continually changing markets.
This new acquisition marks another step forward in Regnology’s ambition to serve the community of regulators and regulated financial institutions with best-in-class solutions designed to address the data conundrum and regulatory complexity with streamlined workflows and increased efficiency.
About Metadata Technology
Metadata Technology provides SDMX solutions for official statistics.
The company was founded in 2005 by the consultants that developed the SDMX standards. The aim of the company is to provide consultancy and software tools in support of SDMX. In this role, it was the first company to provide SDMX training and independent consulting, as well as the first organisation to develop an SDMX Registry.
In recent years Metadata Technology has developed Fusion Registry cloud services to provide automated SDMX data collection, data validation, structure validation, mapping, transformation, and data dissemination. In 2016, Metadata Technology was awarded the contract to replace an international official statistics data collection service with a solution based on the latest Fusion Registry 9 Enterprise Edition. The service will eventually support 450 statistical agencies in 189 countries.
Metadata Technology remains active in the SDMX community and has provided technical advice to the SDMX Technical Working Group (TWG) since its inception in 2011.
About Regnology
Regnology is a leading technology firm on a mission to bring safety and stability to the financial markets. With an exclusive focus on regulatory reporting and more than 34,000 financial institutions, 50 regulators and tax authorities relying on our solutions, we’re uniquely positioned to bring greater data quality, efficiency and cost savings to all market participants. With over 800 employees in 15 countries and a unified data ingestion model powering our work, our clients can quickly implement and derive value from our solutions and easily keep pace with ongoing regulatory changes. Regnology was formed in 2021 when BearingPoint RegTech, a former business unit of BearingPoint Group, joined forces with Vizor Software, a global leader in regulatory and supervisory technology.
For more information about Regnology, connect with us on LinkedIn and Twitter.
Visit our website: www.regnology.net
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230503005061/en/
Contact information
Mireille Adebiyi
Chief Marketing Officer, Regnology
mireille.adebiyi@regnology.net
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New CPS Protection Platform: TXOne Networks Presents SageOne in Hannover25.4.2024 10:04:00 EEST | Press release
TXOne Networks, a leading company in the field of cyber-physical systems (CPS) security, will be presenting its new CPS security platform during the Hannover Messe from 22nd to 26th April 2024 at stand B06 in hall 16: SageOne, which means Wise Man Number One. This central management console provides an overview of the CPS attack surface of the OT environment. All three TXOne product lines can be centrally controlled, namely Stellar for endpoint protection, Element for security inspection and Edge for network defense. The platform offers integrated OT security across the entire lifecycle of the objects to be protected and enables reliable detection and response to threats. SageOne essentially covers three main pillars: CPS Attack Surface Management: Visibility is a cornerstone for cybersecurity. A clear view of the overall security posture helps identify security focal points in an OT environment. SageOne focuses on operational security by honing in on assets and illuminating the securi
Infobip becomes an Oracle Independent Software Vendor partner25.4.2024 10:00:00 EEST | Press release
Infobip, a global cloud communications platform and a member of Oracle PartnerNetwork (OPN), today announced it has enhanced its relationship with Oracle, becoming an Independent Software Vendor (ISV) with access to Oracle Integration Cloud. Businesses using any Oracle solution can access Infobip’s omnichannel platform through Oracle Cloud Marketplace (OCM). They can quickly orchestrate powerful interactions, help increase customer satisfaction, boost sales, and improve campaign performance. Oracle Cloud Marketplace is a one-stop shop for Oracle customers seeking trusted business applications and services offering unique solutions, including ones that extend Oracle Fusion Cloud Applications. Infobip’s communication channels will enable businesses to deliver conversational experiences across many sectors including banking and financial services, retail and ecommerce, and hospitality and leisure. Through Infobip’s collaboration, Oracle users will gain customer insights, enabling them to
Global CIOs geared up to scale AI but organizations aren’t as ready25.4.2024 06:00:00 EEST | Press release
AI is the CIO’s top priority, according to findings of Lenovo’s third annual global CIO report. Inside the Tornado: How AI is Reshaping Corporate IT Today, reveals that while CIOs need to adopt and scale AI urgently, their ambitions are threatened by speed, security, and other organizational functions lagging in AI readiness. In a stark contrast to previous years, CIOs are tabling non-traditional responsibilities to sharpen their focus on core IT functions. Slightly more than half (51%) of CIOs feel AI/ML is an urgent priority to address, matched only by cybersecurity. This urgency is directly correlated to the pressure that CIOs are under to drive business impact, rather than operational maintenance and preservation. 84% of CIOs revealed they are being evaluated on business outcome metrics more than ever before. “Today’s CIOs are working in a tornado of innovation. After years of IT expanding into non-traditional responsibilities, we’re now seeing how AI is forcing CIOs back to their
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area24.4.2024 23:01:00 EEST | Press release
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin is a novel once-weekly echinocandin indicated for the treatment of invasive candidiasis in adults.1 Invasive candidiasis, is a severe, life-threatening infection of the bloodstream and/or deep/visceral tissues.2,3 It affects seriously ill people, especially those with a weakened immune system and the mortality rate can be 40%4 or more.5,6 It can place a large burden on the healthcare system, with the potential for extended treatment regimens and long hospital stays.6 Over the last 15 years, there have been no new treatments and morbidity and mortality rates remain largely the same, indicating the need for alternative treatment options.7,8 “This acquisition places Mundipharma in the best position to realise the full potential of rezafungin inc
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting24.4.2024 23:01:00 EEST | Press release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024. “Our presentations at this year’s ASCO highlight the strength of our growing oncology portfolio and our commitment to developing treatments that address the unmet needs of patients with B-cell malignancies and solid tumors,” Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “The exciting data we will share during ASCO showcase BRUKINSA’s uniquely differentiated clinical profile and add to the growing body of evidence supporting its role across the blood cancer treatment paradigm.” BeiGene will share new data for BRUKINSA (zanubrutinib), which add to the robust efficacy and safety evidence differentiating it within the BTK class. Key highlights include: A network meta-analysis co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom